Quince Therapeutics, Inc. Other Current Assets
Quince Therapeutics, Inc. (QNCX) had Other Current Assets of $393.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $393.00K.
- 2026-03-31: Other Assets, Current $24.00K.
- 2025-12-31: Other Assets, Current $54.00K.
- 2025-09-30: Other Assets, Current $96.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $393.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $54.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $96.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $55.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $32.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $84.00K 10-K · filed 2026-04-10 |
| 2024-09-30 | $55.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $79.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $48.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $81.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $92.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $143.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $179.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $276.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $336.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $387.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $487.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $367.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $495.00K 10-Q · filed 2021-10-29 |
| 2021-06-30 | $438.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $557.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $694.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $629.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $883.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $954.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $688.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $512.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $446.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $387.00K 10-Q · filed 2019-06-12 |
| 2018-12-31 | $68.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |